Npy (neuropeptide Y) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Npy (neuropeptide Y) Rattus norvegicus
Symbol: Npy
Name: neuropeptide Y
RGD ID: 3197
Description: Enables neuropeptide Y receptor binding activity. Involved in several processes, including adult feeding behavior; positive regulation of appetite; and positive regulation of nitrogen compound metabolic process. Located in several cellular components, including perikaryon; perinuclear region of cytoplasm; and terminal bouton. Is active in neuronal dense core vesicle. Used to study alcohol use disorder; childhood absence epilepsy; depressive disorder; and hypertension. Biomarker of several diseases, including brain disease (multiple); depressive disorder; median neuropathy; neurodegenerative disease (multiple); and obesity. Human ortholog(s) of this gene implicated in several diseases, including Huntington's disease; alcohol use disorder; artery disease (multiple); epilepsy (multiple); and type 2 diabetes mellitus. Orthologous to human NPY (neuropeptide Y); PARTICIPATES IN neuropeptide Y metabolic pathway; INTERACTS WITH (+)-pilocarpine; (S)-amphetamine; (S)-nicotine.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: LOC100912228; NPY02; pro-neuropeptide Y; pro-neuropeptide Y-like; RATNPY; RATNPY02
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Allele / Splice: Npyem6Sage  
Genetic Models: iNP-Npyem6Sage/Iusm iNP-Npyem6Sage-/-/Iusm iNP-Npyem6Sage+/-/Iusm
Is Marker For: Strains:   SHR.BN-(Il6-Npy)   iP/Iusm   iNP/Iusm   BB.SHR-(D4Mit6-Spr)/K   NP.P-(D4Rat119-D4Rat55)/Iusm  
QTLs:   Bp21   Bp135  
Candidate Gene For: Eau1 Scwia1 Aia3 Alc18 Bp79 Sach4 Alc16 Alc14 Bw40 Alc21 Alc22 Bp330 Bw126
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.2478,881,294 - 78,888,495 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl478,881,264 - 78,888,495 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx484,098,422 - 84,105,619 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0479,873,911 - 79,881,112 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0478,314,242 - 78,321,437 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0479,557,856 - 79,565,059 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl479,573,998 - 79,581,208 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_6.0 Ensembl479,557,854 - 79,565,097 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.04144,233,753 - 144,240,956 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4478,038,013 - 78,045,187 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1478,314,142 - 78,321,317 (+)NCBI
Celera473,795,148 - 73,802,371 (+)NCBICelera
RH 3.4 Map4507.8RGD
RH 3.4 Map4508.6RGD
Cytogenetic Map4q24NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-pilocarpine  (EXP,ISO)
(R)-noradrenaline  (ISO)
(S)-amphetamine  (EXP)
(S)-nicotine  (EXP)
1,2-dichloroethane  (ISO)
1,3,5-trinitro-1,3,5-triazinane  (EXP)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP,ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,3,7,8-Tetrachlorodibenzofuran  (EXP)
2-deoxy-D-glucose  (EXP)
3,4-methylenedioxymethamphetamine  (EXP,ISO)
4,4'-sulfonyldiphenol  (ISO)
6-propyl-2-thiouracil  (EXP)
acarbose  (EXP)
aflatoxin B1  (ISO)
aldehydo-D-glucose  (EXP)
all-trans-retinoic acid  (ISO)
AM-251  (EXP)
amitriptyline  (EXP)
ammonium chloride  (EXP)
amphetamine  (EXP,ISO)
arsenite(3-)  (ISO)
arsenous acid  (ISO)
aspartame  (EXP)
Aurothioglucose  (ISO)
belinostat  (ISO)
benzo[a]pyrene  (ISO)
bexarotene  (EXP)
bezafibrate  (ISO)
bis(2-ethylhexyl) phthalate  (EXP)
bisphenol A  (EXP,ISO)
bisphenol F  (ISO)
bucladesine  (EXP)
C60 fullerene  (EXP)
cadmium atom  (ISO)
cannabidiol  (EXP)
cannabigerol  (EXP)
capsaicin  (EXP)
capsazepine  (ISO)
carbachol  (ISO)
carbon nanotube  (ISO)
chlordecone  (ISO)
chlorisondamine  (EXP)
chlorpyrifos  (EXP,ISO)
choline  (ISO)
clofibrate  (ISO)
clonidine  (EXP)
clonidine (amino form)  (EXP)
clonidine (imino form)  (EXP)
clozapine  (EXP)
cocaine  (EXP)
corticosterone  (EXP)
cortisol  (ISO)
cytarabine  (ISO)
D-glucose  (EXP)
deoxynivalenol  (EXP)
dexamethasone  (EXP)
dextran sulfate  (ISO)
diarsenic trioxide  (ISO)
diazinon  (EXP)
dieldrin  (EXP)
diprotium oxide  (EXP)
dorsomorphin  (ISO)
entinostat  (ISO)
enzyme inhibitor  (EXP)
ethanol  (EXP,ISO)
fluoxetine  (EXP,ISO)
folic acid  (ISO)
fructose  (EXP)
furan  (EXP)
gentamycin  (EXP)
glucose  (EXP)
Glutathione ethyl ester  (EXP)
glycidol  (EXP)
guanethidine  (EXP,ISO)
haloperidol  (EXP)
Hexamethonium  (EXP)
kainic acid  (EXP,ISO)
ketamine  (ISO)
L-methionine  (ISO)
limonene  (EXP,ISO)
linalool  (EXP,ISO)
lithium atom  (EXP)
lithium hydride  (EXP)
mercury dibromide  (ISO)
metformin  (ISO)
methamphetamine  (EXP,ISO)
methylmercury chloride  (ISO)
monosodium L-glutamate  (EXP,ISO)
morphine  (ISO)
Muraglitazar  (EXP)
nickel atom  (EXP)
nicotine  (EXP)
nitroglycerin  (EXP)
olanzapine  (EXP,ISO)
orlistat  (ISO)
orphenadrine  (EXP)
oxaliplatin  (EXP)
oxidopamine  (EXP)
Oxotremorine  (EXP)
ozone  (EXP)
paclitaxel  (EXP)
panobinostat  (ISO)
paracetamol  (ISO)
paricalcitol  (ISO)
pentobarbital  (ISO)
phenacetin  (EXP)
phenformin  (EXP)
phenylephrine  (ISO)
phenylhydrazine  (EXP)
phenylmercury acetate  (ISO)
phenylpropanolamine  (EXP)
phorbol 13-acetate 12-myristate  (EXP,ISO)
pioglitazone  (ISO)
pirinixic acid  (EXP,ISO)
potassium atom  (EXP,ISO)
potassium chloride  (EXP)
prazosin  (EXP)
progesterone  (EXP,ISO)
propofol  (EXP)
quinpirole  (ISO)
reserpine  (EXP)
resveratrol  (ISO)
rotenone  (EXP)
ruthenium red  (ISO)
SB 431542  (ISO)
SCH 23390  (EXP)
sevoflurane  (EXP)
silicon dioxide  (ISO)
SKF 38393  (ISO)
Soman  (EXP)
streptozocin  (EXP)
succimer  (ISO)
terbutaline  (ISO)
Tesaglitazar  (EXP)
tetrachloromethane  (ISO)
tetrodotoxin  (EXP)
thioacetamide  (EXP)
thiopental  (EXP)
titanium dioxide  (ISO)
topiramate  (EXP)
topotecan  (EXP)
tribromoethanol  (ISO)
tributylstannane  (ISO)
Tributyltin oxide  (ISO)
trichloroethene  (EXP)
trichostatin A  (EXP,ISO)
triclosan  (ISO)
triphenyl phosphate  (ISO)
troglitazone  (EXP)
undecane  (EXP)
valproic acid  (ISO)
vanadium atom  (ISO)
vanadium(0)  (ISO)
vanadyl sulfate  (EXP)
vancomycin  (ISO)
veratridine  (EXP)
vincaleukoblastine  (EXP)
vinclozolin  (EXP)
vorinostat  (ISO)
water  (EXP)
XL147  (ISO)
yohimbine  (EXP)
zalcitabine  (EXP)
zinc atom  (EXP)
zinc(0)  (EXP)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Function

Molecular Pathway Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View

Mammalian Phenotype

References - curated
# Reference Title Reference Citation
1. NPY in rat retina is present in neurons, in endothelial cells and also in microglial and Muller cells. Alvaro AR, etal., Neurochem Int. 2007 Apr;50(5):757-63. Epub 2007 Feb 8.
2. Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons. Bacci A, etal., Proc Natl Acad Sci U S A 2002 Dec 24;99(26):17125-30.
3. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. Beal MF, etal., J Neurosci. 1991 Jun;11(6):1649-59.
4. Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes. Beal MF, etal., Synapse. 1988;2(4):463-7.
5. NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization. Bedoui S, etal., J Neuroimmunol 2002 Nov;132(1-2):25-33.
6. Capture of Dense Core Vesicles at Synapses by JNK-Dependent Phosphorylation of Synaptotagmin-4. Bharat V, etal., Cell Rep. 2017 Nov 21;21(8):2118-2133. doi: 10.1016/j.celrep.2017.10.084.
7. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression. Bjornebekk A, etal., Hippocampus. 2010 Jul;20(7):820-8. doi: 10.1002/hipo.20683.
8. Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats. Byku M, etal., Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2188-97. doi: 10.1152/ajpheart.00384.2008. Epub 2008 Oct 3.
9. Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure. Callanan EY, etal., Am J Physiol Renal Physiol. 2007 Dec;293(6):F1811-7. Epub 2007 Sep 5.
10. The feeding response to melanin-concentrating hormone is attenuated by antagonism of the NPY Y(1)-receptor in the rat. Chaffer CL and Morris MJ, Endocrinology 2002 Jan;143(1):191-7.
11. Alteration of NPY and Y1 receptor in dorsomedial and ventromedial areas of hypothalamus in anorectic tumor-bearing rats. Chance WT, etal., Peptides. 2007 Feb;28(2):295-301. Epub 2007 Jan 17.
12. Neuropeptide Y protects rat cortical neurons against beta-amyloid toxicity and re-establishes synthesis and release of nerve growth factor. Croce N, etal., ACS Chem Neurosci. 2012 Apr 18;3(4):312-8. doi: 10.1021/cn200127e. Epub 2012 Jan 30.
13. Urocortin I inhibits the effects of ghrelin and neuropeptide Y on feeding and energy substrate utilization. Currie PJ, etal., Brain Res. 2011 Apr 18;1385:127-34. doi: 10.1016/j.brainres.2011.01.114.
14. The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age. Dimitrijevic M, etal., Peptides. 2008 Dec;29(12):2179-87. doi: 10.1016/j.peptides.2008.08.017. Epub 2008 Sep 3.
15. Support for involvement of glutamate decarboxylase 1 and neuropeptide y in anxiety susceptibility. Donner J, etal., Am J Med Genet B Neuropsychiatr Genet. 2012 Apr;159B(3):316-27. doi: 10.1002/ajmg.b.32029. Epub 2012 Feb 10.
16. The role of neuropeptide Y and aquaporin 4 in the pathogenesis of intestinal dysfunction caused by traumatic brain injury. Duan H, etal., J Surg Res. 2013 Oct;184(2):1006-12. doi: 10.1016/j.jss.2013.03.096. Epub 2013 Apr 18.
17. Endogenous neuropeptide Y prevents recurrence of experimental febrile seizures by increasing seizure threshold. Dube C, etal., J Mol Neurosci. 2005;25(3):275-84.
18. Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsy. Elms J, etal., PLoS One. 2013 Sep 9;8(9):e73505. doi: 10.1371/journal.pone.0073505. eCollection 2013.
19. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis. Fekete C, etal., Endocrinology 2002 Dec;143(12):4513-9.
20. Immunolesion of norepinephrine and epinephrine afferents to medial hypothalamus alters basal and 2-deoxy-D-glucose-induced neuropeptide Y and agouti gene-related protein messenger ribonucleic acid expression in the arcuate nucleus. Fraley GS and Ritter S, Endocrinology 2003 Jan;144(1):75-83.
21. Neuropeptide Y level in paraventricular nucleus of experimental diabetic rats: correlation with sympathetic activity and body weight. Ganguly PK Int J Gen Med. 2010 Oct 5;3:321-5. doi: 10.2147/IJGM.S7749.
22. Hypothalamic levels of NPY, MCH, and prepro-orexin mRNA during pregnancy and lactation in the rat: role of prolactin. Garcia MC, etal., FASEB J 2003 Aug;17(11):1392-400.
23. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
24. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
25. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. Heilig M, etal., J Psychiatr Res 2004 Mar-Apr;38(2):113-21.
26. Neuropeptide Y is expressed by rat mononuclear blood leukocytes and strongly down-regulated during inflammation. Holler J, etal., J Immunol. 2008 Nov 15;181(10):6906-12.
27. Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease. Hult Lundh S, etal., Hum Mol Genet. 2013 Sep 1;22(17):3485-97. doi: 10.1093/hmg/ddt203. Epub 2013 May 22.
28. Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene related peptide in adult rats. Husum H, etal., Neuropharmacology 2002 May;42(6):798-806.
29. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells. Igura K, etal., Rejuvenation Res. 2011 Aug;14(4):393-403. doi: 10.1089/rej.2010.1129. Epub 2011 May 19.
30. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Karvonen MK, etal., Atherosclerosis. 2001 Nov;159(1):145-51.
31. Localization of quantitative trait loci regulating adjuvant-induced arthritis in rats: evidence for genetic factors common to multiple autoimmune diseases. Kawahito Y, etal., J Immunol 1998 Oct 15;161(8):4411-9
32. Changes in neuropeptide Y protein expression following photothrombotic brain infarction and epileptogenesis. Kharlamov EA, etal., Brain Res. 2007 Jan 5;1127(1):151-62. Epub 2006 Nov 22.
33. Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R. Kloster E, etal., J Mol Med (Berl). 2014 Feb;92(2):177-84.
34. Plasma neuropeptide Y is reduced in patients with Alzheimer's disease. Koide S, etal., Neurosci Lett. 1995 Sep 29;198(2):149-51.
35. Hypothalamic CART is a new anorectic peptide regulated by leptin. Kristensen P, etal., Nature. 1998 May 7;393(6680):72-6.
36. Differential susceptibility of interneurons expressing neuropeptide Y or parvalbumin in the aged hippocampus to acute seizure activity. Kuruba R, etal., PLoS One. 2011;6(9):e24493. doi: 10.1371/journal.pone.0024493. Epub 2011 Sep 6.
37. High-density rat radiation hybrid maps containing over 24,000 SSLPs, genes, and ESTs provide a direct link to the rat genome sequence. Kwitek AE, etal., Genome Res. 2004 Apr;14(4):750-7
38. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Lappalainen J, etal., Arch Gen Psychiatry. 2002 Sep;59(9):825-31.
39. Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability. Li L, etal., J Cardiovasc Transl Res. 2011 Jun;4(3):351-62. doi: 10.1007/s12265-011-9271-5. Epub 2011 Apr 6.
40. Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia. Makarenko IG, etal., Brain Res 2003 Jan 24;961(1):100-8.
41. Increased neuropeptide Y-like immunoreactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients: relationship to HIV encephalopathy. Malessa R, etal., J Neurol Sci. 1996 Mar;136(1-2):154-8.
42. Neuropeptide Y: identification of a novel rat mRNA splice-variant that is downregulated in the hippocampus and the prefrontal cortex of a depression-like model. Melas PA, etal., Peptides. 2012 May;35(1):49-55. doi: 10.1016/j.peptides.2012.02.020. Epub 2012 Mar 3.
43. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
44. Central neuropeptide Y signaling ameliorates N(omega)-nitro-L-arginine methyl ester hypertension in the rat through a Y1 receptor mechanism. Michalkiewicz M, etal., Hypertension 2005 Apr;45(4):780-5. Epub 2005 Feb 7.
45. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors. Morris MJ, etal., Eur J Neurosci. 2007 Feb;25(4):1136-43.
46. Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. Morrison CD, etal., Am J Physiol Endocrinol Metab. 2005 Dec;289(6):E1051-7. Epub 2005 Jul 26.
47. Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation. Nave H, etal., J Neuroimmunol. 2004 Oct;155(1-2):1-12.
48. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
49. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Noe F, etal., Brain. 2008 Jun;131(Pt 6):1506-15. doi: 10.1093/brain/awn079. Epub 2008 May 13.
50. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men. Nordman S, etal., Exp Clin Endocrinol Diabetes. 2005 May;113(5):282-7.
51. Amelioration of dextran sulfate sodium-induced colitis by neuropeptide Y antisense oligodeoxynucleotide. Pang XH, etal., Int J Colorectal Dis. 2010 Sep;25(9):1047-53. doi: 10.1007/s00384-010-0964-z. Epub 2010 Jun 5.
52. Quantitative study of NPY-expressing GABAergic neurons and axons in rat spinal dorsal horn. Polgar E, etal., J Comp Neurol. 2011 Apr 15;519(6):1007-23. doi: 10.1002/cne.22570.
53. Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake. Proulx K, etal., Endocrinology 2002 Dec;143(12):4683-92.
54. Npy deletion in an alcohol non-preferring rat model elicits differential effects on alcohol consumption and body weight. Qiu B, etal., J Genet Genomics. 2016 Jul 20;43(7):421-30. doi: 10.1016/j.jgg.2016.04.010. Epub 2016 Apr 29.
55. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease. Rangani RJ, etal., Peptides. 2012 Feb;33(2):317-28. doi: 10.1016/j.peptides.2012.01.004. Epub 2012 Jan 16.
56. GOA pipeline RGD automated data pipeline
57. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
58. Divergent regulation of hypothalamic neuropeptide Y and agouti-related protein by photoperiod in F344 rats with differential food intake and growth. Ross AW, etal., J Neuroendocrinol. 2009 Jul;21(7):610-9. Epub 2009 Apr 13.
59. A biometrical genome search in rats reveals the multigenic basis of blood pressure variation. Schork NJ, etal., Genome Res 1995 Sep;5(2):164-72
60. Testosterone (T)-induced changes in arcuate nucleus cocaine-amphetamine-regulated transcript and NPY mRNA are attenuated in old compared to young male brown Norway rats: contribution of T to age-related changes in cocaine-amphetamine-regulated transcript and NPY gene expression. Sohn EH, etal., Endocrinology 2002 Mar;143(3):954-63.
61. Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP. Sorensen AT, etal., Exp Neurol. 2009 Feb;215(2):328-33. doi: 10.1016/j.expneurol.2008.10.015. Epub 2008 Nov 10.
62. Neuropeptide Y infusion into the shell region of the rat nucleus accumbens increases extracellular levels of dopamine. Sorensen G, etal., Neuroreport. 2009 Jul 15;20(11):1023-6.
63. Effect of polymorphism on expression of the neuropeptide Y gene in inbred alcohol-preferring and -nonpreferring rats. Spence JP, etal., Neuroscience 2005;131(4):871-6.
64. Regulation of KIF1A-Driven Dense Core Vesicle Transport: Ca2+/CaM Controls DCV Binding and Liprin-α/TANC2 Recruits DCVs to Postsynaptic Sites. Stucchi R, etal., Cell Rep. 2018 Jul 17;24(3):685-700. doi: 10.1016/j.celrep.2018.06.071.
65. Identification of genomic regions controlling experimental autoimmune uveoretinitis in rats. Sun SH, etal., Int Immunol 1999 Apr;11(4):529-34
66. Tentative Sequence Identification Numbers Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
67. Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients. Testa A, etal., J Hypertens. 2010 Aug;28(8):1745-51.
68. Ultrastructural Characterization of Corticotropin-Releasing Factor and Neuropeptide Y in the Rat Locus Coeruleus: Anatomical Evidence for Putative Interactions. Theisen CC, etal., Neuroscience. 2018 Aug 1;384:21-40. doi: 10.1016/j.neuroscience.2018.04.043. Epub 2018 May 22.
69. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Thorsell A, etal., Proc Natl Acad Sci U S A 2000 Nov 7;97(23):12852-7.
70. Neuropeptide Y modulates c-Fos protein expression in the cuneate nucleus and contributes to mechanical hypersensitivity following rat median nerve injury. Tsai YJ, etal., J Neurotrauma. 2009 Sep;26(9):1609-21. doi: 10.1089/neu.2008.0642.
71. Overpressure blast-wave induced brain injury elevates oxidative stress in the hypothalamus and catecholamine biosynthesis in the rat adrenal medulla. Tumer N, etal., Neurosci Lett. 2013 Jun 7;544:62-7. doi: 10.1016/j.neulet.2013.03.042. Epub 2013 Apr 6.
72. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates. Upadhya MA, etal., Neuropeptides. 2009 Aug;43(4):303-14. doi: 10.1016/j.npep.2009.05.003. Epub 2009 Jun 24.
73. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet. Wang C, etal., Horm Metab Res. 2007 Apr;39(4):262-7.
74. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway. Wang SJ, Neuroscience. 2005;134(3):987-1000. doi: 10.1016/j.neuroscience.2005.04.053.
75. Localization in rats of genetic loci regulating susceptibility to experimental erosive arthritis and related autoimmune diseases. Wilder RL, etal., Transplant Proc 1999 May;31(3):1585-8
76. Transcellular induction of neuropeptide Y expression by NT4 and BDNF. Wirth MJ, etal., Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3064-9. Epub 2005 Feb 9.
77. Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue Xu ZQ, etal., Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Apr;16(4):218-20.
78. Expression, physiological action, and coexpression patterns of neuropeptide Y in rat taste-bud cells. Zhao FL, etal., Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11100-5. Epub 2005 Jul 22.
79. [Number changes and axonal sprouting of neuropeptide Y interneurons in the hippocampus of pilocarpine-induced rats]. Zhiguo W, etal., Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Feb;34(2):93-8.
Additional References at PubMed
PMID:2834371   PMID:3031663   PMID:3031687   PMID:3413293   PMID:8837218   PMID:9067840   PMID:9623984   PMID:9756788   PMID:10698177   PMID:11738809   PMID:11856342   PMID:11897270  
PMID:11914579   PMID:11932938   PMID:12030805   PMID:12069594   PMID:12093484   PMID:12429884   PMID:12450741   PMID:12450742   PMID:12576193   PMID:12590942   PMID:12686755   PMID:12727330  
PMID:12782392   PMID:12786976   PMID:12842868   PMID:12895522   PMID:12902638   PMID:12914981   PMID:12919938   PMID:14551170   PMID:14617575   PMID:15123022   PMID:15127943   PMID:15245875  
PMID:15567472   PMID:15576634   PMID:15582708   PMID:15618885   PMID:15619124   PMID:15652508   PMID:15680466   PMID:15716245   PMID:15716408   PMID:15789763   PMID:15926937   PMID:16051880  
PMID:16087729   PMID:16154634   PMID:16195495   PMID:16198490   PMID:16210372   PMID:16266747   PMID:16336998   PMID:16383008   PMID:16387449   PMID:16426702   PMID:16675522   PMID:16721031  
PMID:16728494   PMID:16867179   PMID:16888209   PMID:16965293   PMID:17011171   PMID:17023531   PMID:17081520   PMID:17154253   PMID:17289093   PMID:17388940   PMID:17400722   PMID:17462823  
PMID:17464216   PMID:17467917   PMID:17684035   PMID:17690163   PMID:17976913   PMID:17989139   PMID:18001323   PMID:18032527   PMID:18094253   PMID:18164503   PMID:18242853   PMID:18308474  
PMID:18323405   PMID:18331583   PMID:18384674   PMID:18389390   PMID:18467436   PMID:18502321   PMID:18504079   PMID:18535107   PMID:18539096   PMID:18544708   PMID:18573184   PMID:18573695  
PMID:18588949   PMID:18598846   PMID:18603306   PMID:18835268   PMID:18937973   PMID:18955035   PMID:19009650   PMID:19017729   PMID:19036961   PMID:19063928   PMID:19095023   PMID:19151514  
PMID:19183337   PMID:19211911   PMID:19229719   PMID:19255506   PMID:19295167   PMID:19383429   PMID:19497417   PMID:19553928   PMID:19559985   PMID:19609086   PMID:19620061   PMID:19671088  
PMID:19817504   PMID:19818818   PMID:19877509   PMID:19879928   PMID:19934016   PMID:19968967   PMID:20012021   PMID:20028355   PMID:20051529   PMID:20179883   PMID:20219870   PMID:20335227  
PMID:20531438   PMID:20610828   PMID:20633633   PMID:20814066   PMID:20817751   PMID:20836657   PMID:20846339   PMID:20945070   PMID:21061149   PMID:21079358   PMID:21162274   PMID:21179736  
PMID:21428728   PMID:21453769   PMID:21473895   PMID:21527271   PMID:21558160   PMID:21589937   PMID:21799827   PMID:21821286   PMID:21855588   PMID:22365383   PMID:22437342   PMID:22461566  
PMID:22474320   PMID:22513398   PMID:22527118   PMID:22643238   PMID:22659471   PMID:22708658   PMID:22832533   PMID:22917777   PMID:22938859   PMID:22964363   PMID:23024812   PMID:23090692  
PMID:23123350   PMID:23271280   PMID:23303411   PMID:23312492   PMID:23313404   PMID:23321476   PMID:23457218   PMID:23526718   PMID:23644054   PMID:23652932   PMID:23680526   PMID:24094067  
PMID:24183962   PMID:24291064   PMID:24308227   PMID:24444822   PMID:24549602   PMID:24582971   PMID:24779394   PMID:24829502   PMID:25011012   PMID:25109664   PMID:25146309   PMID:25197671  
PMID:25241802   PMID:25482245   PMID:25561025   PMID:25635612   PMID:25775546   PMID:25825358   PMID:25952775   PMID:25993471   PMID:26012590   PMID:26047956   PMID:26086271   PMID:26188175  
PMID:26490304   PMID:26514659   PMID:26538454   PMID:26541912   PMID:26561644   PMID:26589184   PMID:26702900   PMID:26707636   PMID:26779765   PMID:27805869   PMID:27855650   PMID:28062253  
PMID:28065829   PMID:28097455   PMID:28438668   PMID:28575455   PMID:28914170   PMID:29425286   PMID:29442423   PMID:29519725   PMID:29777700   PMID:29850786   PMID:30146352   PMID:30227410  
PMID:30950054   PMID:31915051   PMID:32200588   PMID:33044017   PMID:33966606   PMID:34666848   PMID:35008014   PMID:35313782   PMID:36565980  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.2478,881,294 - 78,888,495 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl478,881,264 - 78,888,495 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx484,098,422 - 84,105,619 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0479,873,911 - 79,881,112 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0478,314,242 - 78,321,437 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0479,557,856 - 79,565,059 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl479,573,998 - 79,581,208 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_6.0 Ensembl479,557,854 - 79,565,097 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.04144,233,753 - 144,240,956 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4478,038,013 - 78,045,187 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1478,314,142 - 78,321,317 (+)NCBI
Celera473,795,148 - 73,802,371 (+)NCBICelera
RH 3.4 Map4507.8RGD
RH 3.4 Map4508.6RGD
Cytogenetic Map4q24NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh38724,284,190 - 24,291,862 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl724,284,188 - 24,291,862 (+)EnsemblGRCh38hg38GRCh38
GRCh37724,323,809 - 24,331,481 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36724,290,334 - 24,298,002 (+)NCBINCBI36Build 36hg18NCBI36
Build 34724,097,048 - 24,104,717NCBI
Celera724,312,617 - 24,320,302 (+)NCBICelera
Cytogenetic Map7p15.3NCBI
HuRef724,208,802 - 24,216,490 (+)NCBIHuRef
CHM1_1724,325,406 - 24,333,092 (+)NCBICHM1_1
T2T-CHM13v2.0724,422,184 - 24,429,876 (+)NCBIT2T-CHM13v2.0
CRA_TCAGchr7v2724,375,683 - 24,383,371 (+)NCBI
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm39649,799,690 - 49,806,487 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl649,799,690 - 49,806,487 (+)EnsemblGRCm39 Ensembl
GRCm38649,822,710 - 49,829,507 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl649,822,710 - 49,829,507 (+)EnsemblGRCm38mm10GRCm38
MGSCv37649,772,728 - 49,779,506 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36649,752,315 - 49,759,093 (+)NCBIMGSCv36mm8
Celera650,334,213 - 50,340,981 (+)NCBICelera
Cytogenetic Map6B2.3NCBI
cM Map624.04NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_00495541026,348,504 - 26,355,297 (+)EnsemblChiLan1.0
ChiLan1.0NW_00495541026,348,388 - 26,355,232 (+)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan1777,469,833 - 77,477,581 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0724,963,056 - 24,970,803 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1724,566,963 - 24,574,657 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl724,568,041 - 24,574,657 (+)Ensemblpanpan1.1panPan2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.11437,824,579 - 37,831,289 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl1437,823,861 - 37,831,443 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha1437,373,133 - 37,380,851 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.01437,758,052 - 37,765,788 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl1437,758,938 - 37,765,943 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.11437,872,113 - 37,879,841 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.01437,564,477 - 37,572,202 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.01437,908,665 - 37,916,390 (+)NCBIUU_Cfam_GSD_1.0
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_02440511882,077,623 - 82,085,085 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049364781,290,505 - 1,296,874 (+)EnsemblSpeTri2.0
SpeTri2.0NW_0049364781,289,437 - 1,296,819 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1 Ensembl1847,985,725 - 47,992,667 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11847,985,796 - 47,993,726 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21852,929,745 - 52,937,666 (-)NCBISscrofa10.2Sscrofa10.2susScr3
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.12134,068,533 - 34,076,205 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl2134,068,530 - 34,075,127 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366604270,564,869 - 70,572,551 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla_female_1.0 EnsemblNW_0046247396,277,612 - 6,285,397 (-)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046247396,277,704 - 6,285,454 (-)NCBIHetGla_female_1.0HetGla 1.0hetGla2


Variants in Npy
44 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:127
Count of miRNA genes:106
Interacting mature miRNAs:110
Prediction methods:Microtar, Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
619616Bp79Blood pressure QTL 790.0292arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)4521460278882945Rat
2303168Bp330Blood pressure QTL 3304.250.017arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)45214602146446691Rat
631261Tcas3Tongue tumor susceptibility QTL 36.88tongue integrity trait (VT:0010553)number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950)41081417091360527Rat
2316958Gluco58Glucose level QTL 5810blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)411320076180699135Rat
8655906Rf60Renal function QTL 603.8blood creatinine amount (VT:0005328)creatinine clearance (CMO:0000765)42949419581006281Rat
12798520Anxrr55Anxiety related response QTL 554.450.01locomotor behavior trait (VT:0001392)number of rearing movements with lid-pushing in an experimental apparatus (CMO:0002715)432583980114627242Rat
8552782Vie1Viral induced encephalitis QTL 126.4brain integrity trait (VT:0010579)encephalitis incidence/prevalence measurement (CMO:0002361)43443048482490359Rat
8552801Bw143Body weight QTL 1437.3body mass (VT:0001259)change in body weight to body weight ratio (CMO:0002216)43443048482490359Rat
8552809Vie5Viral induced encephalitis QTL 525.3brain integrity trait (VT:0010579)encephalitis incidence/prevalence measurement (CMO:0002361)43443048482490359Rat
8655961Kidm43Kidney mass QTL 4318kidney mass (VT:0002707)both kidneys wet weight (CMO:0000085)436303261103194984Rat
1358352Srcrt3Stress Responsive Cort QTL 32.29blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)438465774146803430Rat
1300139Hrtrt6Heart rate QTL 62.85heart pumping trait (VT:2000009)heart rate (CMO:0000002)439524264116179656Rat
61445Strs3Sensitivity to stroke QTL 33cerebrum integrity trait (VT:0010549)post-insult time to onset of cerebrovascular lesion (CMO:0002343)44043338885433388Rat
8694439Bw168Body weight QTL 1689.570.001retroperitoneal fat pad mass (VT:0010430)retroperitoneal fat pad weight to body weight ratio (CMO:0000635)44043341485433414Rat
6893678Bw108Body weight QTL 1082.60.006body mass (VT:0001259)body weight (CMO:0000012)44345797688457976Rat
1576305Emca6Estrogen-induced mammary cancer QTL 65.8mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)444463720155883716Rat
1354612Foco1Food consumption QTL 18.87eating behavior trait (VT:0001431)food intake rate (CMO:0000427)444463908148090542Rat
1354660Salc1Saline consumption QTL 111.26drinking behavior trait (VT:0001422)saline drink intake rate (CMO:0001627)444463908148090542Rat
2312567Glom19Glomerulus QTL 191.90.006kidney glomerulus morphology trait (VT:0005325)index of glomerular damage (CMO:0001135)445456990146803430Rat
1298082Stresp4Stress response QTL 4blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)450119848146803430Rat
4889969Bss96Bone structure and strength QTL 964.9tibia size trait (VT:0100001)tibia cortical bone volume (CMO:0001725)45664777678882945Rat
4889972Bss97Bone structure and strength QTL 975.6tibia size trait (VT:0100001)tibia total bone volume (CMO:0001724)45664777678882945Rat
5685009Bmd86Bone mineral density QTL 863.7tibia mineral mass (VT:1000283)bone mineral density (CMO:0001226)45664777678882945Rat
5685012Bmd87Bone mineral density QTL 875.1tibia mineral mass (VT:1000283)bone mineral content (CMO:0001554)45664777678882945Rat
70200Alc18Alcohol consumption QTL 189.2drinking behavior trait (VT:0001422)ethanol intake volume to total fluid intake volume ratio (CMO:0001591)456647873149491524Rat
1641833Alc21Alcohol consumption QTL 218.60.0001drinking behavior trait (VT:0001422)ethanol drink intake rate (CMO:0001407)456698790126192555Rat
634311Sach7Saccharin preference QTL 7taste sensitivity trait (VT:0001986)saccharin intake volume to total fluid intake volume ratio (CMO:0001601)45711443281266970Rat
631546Bp86Blood pressure QTL 863.2arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)45711443291360801Rat
61336Bp21Blood pressure QTL 214.6arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)45711470578881294Rat
1358363Sradr3Stress Responsive Adrenal Weight QTL 36.19adrenal gland mass (VT:0010420)both adrenal glands wet weight (CMO:0000164)457486946102486946Rat
1558651Swd3Spike wave discharge measurement QTL 34.620.000024brain electrophysiology trait (VT:0010557)brain spike-and-wave discharge frequency (CMO:0001742)45843213392991462Rat
631671Iddm11Insulin dependent diabetes mellitus QTL 113.60.0012blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)45863587778886137Rat
738009Sach4Saccharine consumption QTL 44.90.000016consumption behavior trait (VT:0002069)saccharin intake volume to total fluid intake volume ratio (CMO:0001601)459948935154902892Rat
738016Alc16Alcohol consumption QTL 163.60.00015consumption behavior trait (VT:0002069)ethanol drink intake rate to body weight ratio (CMO:0001616)459948935154902892Rat
738031Alc14Alcohol consumption QTL 147.60.00003consumption behavior trait (VT:0002069)ethanol drink intake rate to body weight ratio (CMO:0001616)459948935154902892Rat
1578657Bss12Bone structure and strength QTL 128.9femur morphology trait (VT:0000559)femoral neck cross-sectional area (CMO:0001697)460220938105220938Rat
1578658Bss13Bone structure and strength QTL 138femur strength trait (VT:0010010)femoral neck polar moment of inertia (CMO:0001670)460220938105220938Rat
2300179Bmd50Bone mineral density QTL 505.90.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)460928534105928534Rat
1549843Bw53Body weight QTL 530.0001body mass (VT:0001259)body weight gain (CMO:0000420)461697658103194791Rat
1549839Bw52Body weight QTL 520.0001body mass (VT:0001259)body weight gain (CMO:0000420)461697658115089733Rat
61418Pia5Pristane induced arthritis QTL 54.5joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)462277855128289560Rat
6478743Anxrr40Anxiety related response QTL 400.83076defecation behavior trait (VT:0010462)defecation rate (CMO:0000998)462753847107753847Rat
6478772Anxrr49Anxiety related response QTL 490.15488defecation behavior trait (VT:0010462)defecation rate (CMO:0000998)462753847107753847Rat
6478684Anxrr30Anxiety related response QTL 300.00087defecation behavior trait (VT:0010462)defecation rate (CMO:0000998)462753847107753847Rat
631651Bp124Blood pressure QTL 1243arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)462879517107879517Rat
7394826Bw126Body weight QTL 1260.002body mass (VT:0001259)body weight gain (CMO:0000420)46293326987483707Rat
8552807Vie4Viral induced encephalitis QTL 47.3brain integrity trait (VT:0010579)encephalitis incidence/prevalence measurement (CMO:0002361)46293350882490359Rat
70192BpQTLcluster5Blood pressure QTL cluster 54.183arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)462933508114921294Rat
70192BpQTLcluster5Blood pressure QTL cluster 54.183arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)462933508114921294Rat
70192BpQTLcluster5Blood pressure QTL cluster 54.183arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)462933508114921294Rat
70192BpQTLcluster5Blood pressure QTL cluster 54.183arterial blood pressure trait (VT:2000000)percent change in mean arterial blood pressure (CMO:0002035)462933508114921294Rat
70192BpQTLcluster5Blood pressure QTL cluster 54.183arterial blood pressure trait (VT:2000000)percent change in systolic blood pressure (CMO:0000747)462933508114921294Rat
70192BpQTLcluster5Blood pressure QTL cluster 54.183arterial blood pressure trait (VT:2000000)absolute change in pulse pressure (CMO:0001882)462933508114921294Rat
70192BpQTLcluster5Blood pressure QTL cluster 54.183arterial blood pressure trait (VT:2000000)absolute change in mean arterial blood pressure (CMO:0000533)462933508114921294Rat
631674Iddm14Insulin dependent diabetes mellitus QTL 14blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)464528739157573521Rat
2312569Pur19Proteinuria QTL 193.40.001urine total protein amount (VT:0000032)urine total protein excretion rate (CMO:0000756)46588210796130297Rat
61330Eau1Experimental allergic uveoretinitis QTL 10.0003uvea integrity trait (VT:0010551)experimental autoimmune uveitis score (CMO:0001504)470362013132642728Rat
634344Hcar7Hepatocarcinoma resistance QTL 77.8liver integrity trait (VT:0010547)liver tumorous lesion area to total liver area ratio (CMO:0001075)470808386115808386Rat
634344Hcar7Hepatocarcinoma resistance QTL 77.8liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)470808386115808386Rat
631646Stl4Serum triglyceride level QTL 46.50.0001blood triglyceride amount (VT:0002644)plasma triglyceride level (CMO:0000548)473169846132642728Rat
724522Bp146Blood pressure QTL 1462.20.0021arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)473630210118630210Rat
2302051Pia28Pristane induced arthritis QTL 285.30.001blood autoantibody amount (VT:0003725)serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112)473630210118630210Rat
70167Bw22Body weight QTL 223.1body mass (VT:0001259)body weight (CMO:0000012)476647384117676292Rat
1357342Bw40Body weight QTL 400.001body mass (VT:0001259)body weight (CMO:0000012)476647384117676292Rat
631662Hcar2Hepatocarcinoma resistance QTL 23.10.0003liver integrity trait (VT:0010547)volume of individual liver tumorous lesion (CMO:0001078)478878504123878504Rat
631556Bp135Blood pressure QTL 1350.017arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)478881294117676292Rat
2317586Eae25Experimental allergic encephalomyelitis QTL 259.300000190734863nervous system integrity trait (VT:0010566)experimental autoimmune encephalomyelitis severity score (CMO:0001419)47888281783007655Rat
2317586Eae25Experimental allergic encephalomyelitis QTL 259.300000190734863nervous system integrity trait (VT:0010566)percentage of study population developing experimental autoimmune encephalomyelitis during a period of time (CMO:0001047)47888281783007655Rat
2317586Eae25Experimental allergic encephalomyelitis QTL 259.300000190734863nervous system integrity trait (VT:0010566)post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422)47888281783007655Rat
2317586Eae25Experimental allergic encephalomyelitis QTL 259.300000190734863nervous system integrity trait (VT:0010566)experimental autoimmune encephalomyelitis duration (CMO:0001424)47888281783007655Rat
61364Iddm2Insulin dependent diabetes mellitus QTL 2blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)478885890102684881Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,882,817 - 78,882,954 (+)MAPPERmRatBN7.2
Rnor_6.0479,575,534 - 79,575,667NCBIRnor6.0
Rnor_6.0479,559,380 - 79,559,514NCBIRnor6.0
Rnor_5.04144,249,326 - 144,249,459UniSTSRnor5.0
Rnor_5.04144,235,277 - 144,235,411UniSTSRnor5.0
RGSC_v3.4478,039,509 - 78,039,646RGDRGSC3.4
RGSC_v3.4478,039,510 - 78,039,646UniSTSRGSC3.4
RGSC_v3.1478,315,639 - 78,315,776RGD
Celera473,796,672 - 73,796,816UniSTS
RH 3.4 Map4504.2UniSTS
RH 3.4 Map4504.2RGD
RH 2.0 Map4547.5RGD
Cytogenetic Map4q24UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,882,817 - 78,882,945 (+)MAPPERmRatBN7.2
Rnor_6.0479,575,534 - 79,575,658NCBIRnor6.0
Rnor_6.0479,559,380 - 79,559,505NCBIRnor6.0
Rnor_5.04144,249,326 - 144,249,450UniSTSRnor5.0
Rnor_5.04144,235,277 - 144,235,402UniSTSRnor5.0
RGSC_v3.4478,039,510 - 78,039,637UniSTSRGSC3.4
RGSC_v3.4478,039,509 - 78,039,637RGDRGSC3.4
Celera473,796,672 - 73,796,807UniSTS
Cytogenetic Map4q24UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,878,504 - 78,878,711 (+)MAPPERmRatBN7.2
Rnor_6.0479,570,971 - 79,571,177NCBIRnor6.0
Rnor_6.0479,555,067 - 79,555,273NCBIRnor6.0
Rnor_5.04144,230,964 - 144,231,170UniSTSRnor5.0
Rnor_5.04144,244,763 - 144,244,969UniSTSRnor5.0
RGSC_v3.4478,035,196 - 78,035,403RGDRGSC3.4
RGSC_v3.4478,035,197 - 78,035,403UniSTSRGSC3.4
RGSC_v3.1478,311,326 - 78,311,533RGD
Celera473,792,358 - 73,792,564UniSTS
RH 3.4 Map4504.3UniSTS
RH 3.4 Map4504.3RGD
RH 2.0 Map4551.7RGD
SHRSP x BN Map437.38RGD
FHH x ACI Map446.9099RGD
Cytogenetic Map4q24UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,885,989 - 78,886,137 (+)MAPPERmRatBN7.2
Rnor_6.0479,578,703 - 79,578,854NCBIRnor6.0
Rnor_6.0479,562,550 - 79,562,701NCBIRnor6.0
Rnor_5.04144,252,495 - 144,252,646UniSTSRnor5.0
Rnor_5.04144,238,447 - 144,238,598UniSTSRnor5.0
RGSC_v3.4478,042,681 - 78,042,833RGDRGSC3.4
RGSC_v3.4478,042,682 - 78,042,833UniSTSRGSC3.4
RGSC_v3.1478,318,811 - 78,318,963RGD
Celera473,799,852 - 73,800,013UniSTS
RH 3.4 Map4508.4UniSTS
RH 3.4 Map4508.4RGD
RH 2.0 Map4543.9RGD
Cytogenetic Map4q24UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,885,867 - 78,886,157 (+)MAPPERmRatBN7.2
Rnor_6.0479,578,581 - 79,578,874NCBIRnor6.0
Rnor_6.0479,562,428 - 79,562,721NCBIRnor6.0
Rnor_5.04144,238,325 - 144,238,618UniSTSRnor5.0
Rnor_5.04144,252,373 - 144,252,666UniSTSRnor5.0
RGSC_v3.4478,042,559 - 78,042,853RGDRGSC3.4
RGSC_v3.4478,042,560 - 78,042,853UniSTSRGSC3.4
RGSC_v3.1478,318,689 - 78,318,983RGD
Celera473,799,730 - 73,800,033UniSTS
FHH x ACI Map446.9099RGD
FHH x ACI Map446.9099UniSTS
Cytogenetic Map4q24UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,885,890 - 78,886,189 (+)MAPPERmRatBN7.2
Rnor_6.0479,562,451 - 79,562,753RGDRnor6.0
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,882,815 - 78,882,945 (+)MAPPERmRatBN7.2
Rnor_6.0479,575,532 - 79,575,658NCBIRnor6.0
Rnor_6.0479,559,378 - 79,559,505NCBIRnor6.0
Rnor_5.04144,235,275 - 144,235,402UniSTSRnor5.0
Rnor_5.04144,249,324 - 144,249,450UniSTSRnor5.0
RGSC_v3.4478,039,507 - 78,039,637RGDRGSC3.4
RGSC_v3.4478,039,508 - 78,039,637UniSTSRGSC3.4
RGSC_v3.1478,315,637 - 78,315,767RGD
Celera473,796,670 - 73,796,807UniSTS
RH 3.4 Map4500.0RGD
RH 3.4 Map4500.0UniSTS
RH 2.0 Map4554.5RGD
Cytogenetic Map4q24UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,882,815 - 78,882,964 (+)MAPPERmRatBN7.2
Rnor_6.0479,575,532 - 79,575,677NCBIRnor6.0
Rnor_6.0479,559,378 - 79,559,524NCBIRnor6.0
Rnor_5.04144,235,275 - 144,235,421UniSTSRnor5.0
Rnor_5.04144,249,324 - 144,249,469UniSTSRnor5.0
RGSC_v3.4478,039,507 - 78,039,656RGDRGSC3.4
RGSC_v3.4478,039,508 - 78,039,656UniSTSRGSC3.4
RGSC_v3.1478,315,637 - 78,315,786RGD
Celera473,796,670 - 73,796,826UniSTS
FHH x ACI Map446.34RGD
FHH x ACI Map446.34UniSTS
Cytogenetic Map4q24UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,885,890 - 78,886,189 (+)MAPPERmRatBN7.2
Rnor_6.0479,578,604 - 79,578,906NCBIRnor6.0
Rnor_6.0479,562,451 - 79,562,753NCBIRnor6.0
Rnor_5.04144,238,348 - 144,238,650UniSTSRnor5.0
Rnor_5.04144,252,396 - 144,252,698UniSTSRnor5.0
RGSC_v3.4478,042,583 - 78,042,885UniSTSRGSC3.4
Celera473,799,753 - 73,800,065UniSTS
Cytogenetic Map4q24UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,886,166 - 78,886,421 (+)MAPPERmRatBN7.2
Rnor_6.0479,578,884 - 79,579,138NCBIRnor6.0
Rnor_6.0479,562,731 - 79,562,985NCBIRnor6.0
Rnor_5.04144,252,676 - 144,252,930UniSTSRnor5.0
Rnor_5.04144,238,628 - 144,238,882UniSTSRnor5.0
RGSC_v3.4478,042,863 - 78,043,117UniSTSRGSC3.4
Celera473,800,043 - 73,800,297UniSTS
RH 3.4 Map4508.6UniSTS
Cytogenetic Map4q24UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,885,833 - 78,885,943 (+)MAPPERmRatBN7.2
Rnor_6.0479,578,547 - 79,578,656NCBIRnor6.0
Rnor_6.0479,562,394 - 79,562,503NCBIRnor6.0
Rnor_5.04144,238,291 - 144,238,400UniSTSRnor5.0
Rnor_5.04144,252,339 - 144,252,448UniSTSRnor5.0
RGSC_v3.4478,042,526 - 78,042,635UniSTSRGSC3.4
Celera473,799,696 - 73,799,805UniSTS
Cytogenetic Map4q24UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2478,888,361 - 78,888,460 (+)MAPPERmRatBN7.2
Rnor_6.0479,581,079 - 79,581,177NCBIRnor6.0
Rnor_6.0479,564,926 - 79,565,024NCBIRnor6.0
Rnor_5.04144,240,823 - 144,240,921UniSTSRnor5.0
Rnor_5.04144,254,871 - 144,254,969UniSTSRnor5.0
RGSC_v3.4478,045,058 - 78,045,156UniSTSRGSC3.4
Celera473,802,238 - 73,802,336UniSTS
Cytogenetic Map4q24UniSTS

Related Rat Strains
The following Strains have been annotated to Npy

Genetic Models
This gene Npy is modified in the following models/strains


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

endocrine system exocrine system hemolymphoid system hepatobiliary system nervous system reproductive system
Below cutoff 4 4 1 4 15 1


RefSeq Acc Id: ENSRNOT00000013145   ⟹   ENSRNOP00000013146
Rat AssemblyChrPosition (strand)Source
Rnor_6.0 Ensembl479,557,854 - 79,565,097 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000074351   ⟹   ENSRNOP00000066713
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl478,881,264 - 78,888,495 (+)Ensembl
Rnor_6.0 Ensembl479,573,998 - 79,581,208 (+)Ensembl
RefSeq Acc Id: NM_012614   ⟹   NP_036746
RefSeq Status: REVIEWED
Rat AssemblyChrPosition (strand)Source
mRatBN7.2478,881,294 - 78,888,495 (+)NCBI
Rnor_6.0479,557,856 - 79,565,059 (+)NCBI
Rnor_5.04144,233,753 - 144,240,956 (+)NCBI
RGSC_v3.4478,038,013 - 78,045,187 (+)RGD
Celera473,795,148 - 73,802,371 (+)NCBI
RefSeq Acc Id: NP_036746   ⟸   NM_012614
- Peptide Label: preproprotein
- UniProtKB: P07808 (UniProtKB/Swiss-Prot),   F2W8A6 (UniProtKB/TrEMBL),   M0RAZ3 (UniProtKB/TrEMBL),   F2W8A7 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000013146   ⟸   ENSRNOT00000013145
RefSeq Acc Id: ENSRNOP00000066713   ⟸   ENSRNOT00000074351

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P07808-F1-model_v2 AlphaFold P07808 1-98 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:3197 AgrOrtholog
BIND 133988
BioCyc Gene G2FUF-44903 BioCyc
Ensembl Genes ENSRNOG00000009768 Ensembl
  ENSRNOG00000046449 Ensembl, ENTREZGENE, UniProtKB/TrEMBL
Ensembl Protein ENSRNOP00000066713 ENTREZGENE
  ENSRNOP00000066713.3 UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000074351 ENTREZGENE
  ENSRNOT00000074351.3 UniProtKB/TrEMBL
Gene3D-CATH UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
InterPro Pancreatic_hormone-like UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Pancreatic_hormone-like_CS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:24604 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  PTHR10533 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam Hormone_3 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PhenoGen Npy PhenoGen
SMART PAH UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
TIGR TC232176
UniProt Secondary M0RAZ3 UniProtKB/TrEMBL

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2021-03-09 Npy  neuropeptide Y  LOC100912228  pro-neuropeptide Y-like  Data Merged 737654 PROVISIONAL
2012-07-05 LOC100912228  pro-neuropeptide Y-like      Symbol and Name status set to provisional 70820 PROVISIONAL
2002-06-10 Npy  Neuropeptide Y      Symbol and Name status set to approved 70586 APPROVED

RGD Curation Notes
Note Type Note Reference
gene_expression present in the hypothalamus of obese rats, especially in the paraventricular nucleus 70437
gene_expression abundant in central and peripheral nervous system 628512
gene_expression expressed throughout nervous system; increased expression in brain areas undergoing seizures 628420
gene_function hypothalamic-derived neuropeptide 628420
gene_function hypothalamic-derived neuropeptide 628512
gene_function inhibitory neurotransmitter that controls blood pressure 1357410
gene_other exogenous Npy has long-lasting effects on postsynaptic current amplitude in neocortex 628420
gene_physical_interaction binds to G protein coupled pancreatic polypeptide (Pp) receptors Y1,Y2 and Y5 628420
gene_process regulates appetite 70437
gene_process activates G-protein coupled receptors 70437
gene_process may function as an endogenous antiepileptic agent 628512
gene_process involved in energy homeostasis 628420
gene_process may be involved in modulation of Ca2+ dependent GABA release onto pyramidal neurons 628420
gene_process involved in modulation of feeding behaviour, anxiety, memory consolidation, and regulation of blood pressure; may decrease excitatory postsynaptic current and increase monosynaptic inhibitory postsynaptic current 628420
gene_process mediates effects of leptin on energy homeostasis; may influence hypothalamic-pituitary-thyroid axis (HPT axis) 628420
gene_process mediates the control of stress and fear related behavior 1357416
gene_regulation decrease in hypothalamic NPY innervation observed in anorectic TB rats 727497
gene_transcript polymorphism at position +4666 defined by microsatellite marker D4Mit7, contributes to reduced levels of mRNA expression in brain regions of alcohol preferring (iP) rats 1357412